The 4000th eye tumour patient treated with protons at HZB
Overview: Number of patients treated with prontons at HZB from 1998 to 2020. © HZB/S. Kodalle
On 19 February 2021, the 4000th eye tumour patient received irradiation with protons, performed by a joint team from Helmholtz-Zentrum Berlin (HZB) and Charité - Universitätsmedizin Berlin. The number of patients treated in 2020 remained at the previous year's level despite the more difficult corona conditions. The treatment in Berlin-Wannsee is only available for uveal melanomas of the eye. The proton accelerator at HZB is the only therapy site for this disease in Germany.
For more than 20 years, Charité - Universitätsmedizin Berlin and Helmholtz-Zentrum Berlin (HZB) have jointly offered irradiation of eye tumours with protons. For this purpose, the HZB operates a proton accelerator, while the medical care of patients is provided by the Charité.
"We congratulate the joint team on this great success and thank them for doing everything they could under the difficult pandemic conditions to maintain the operation of the life-saving eye tumour therapy," says Prof. Bernd Rech, spokesman for the scientific management of HZB.
500 to 600 people contract malignant uveal melanoma in Germany every year. In 97 percent of cases, the tumour can be completely destroyed by irradiation with protons. In most cases, not only the eye but also the vision can be preserved to a satisfactory degree. Radiation with protons is a particularly effective method: the energy of the proton beam can be adjusted in such a way that practically only the tumour receives the radiation, while the surrounding healthy tissue is spared.
- Superconducting TES array X-ray spectrometer goes into operation at BESSY IIEurope's first and only TES-spectrometer at a synchrotron source is now in operation at BESSY II, developed within a collaboration between the HZB, the MPI-CEC (Mühlheim-an-der-Ruhr, Germany) and the NIST (Boulder CO, USA). The photon detection efficiency of the new instrument exceeds that of wavelength-dispersive X-ray emission spectrometers by a factor of 100 to 1000. It will be used to investigate the electronic properties of atomically thin layers, nanostructures and highly diluted atomic and molecular samples. The team is looking forward to receiving exciting research proposals from the user community.
- A New Era in Catalysis: ASCEND Launch in Berlin, €30 Million in FundingOn 11 June 2026, the Helmholtz-Zentrum Berlin (HZB) in Adlershof hosted the launch of ASCEND (Accelerated Solutions for Catalysis using Emerging Nanotechnology and Digital Innovation). The event took place in the presence of the Minister of Research, Dorothee Bär, President of the Helmholtz Association, Prof. Dr. Martin Keller, and President of the Max Planck Society, Prof. Dr. Patrick Cramer. Bringing together leading partners from industry and research, ASCEND is supported by BMFTR with €30 million in funding and officially started on 1 April 2026. The initiative aims to accelerate the discovery of next-generation catalysts and enable more sustainable chemical processes.
- X-ray analysis reveals overpainted fascist symbolsErich Mercker was a successful painter during the Nazi era and in the years that followed. After 1945, he covered up Nazi symbols in at least one of his paintings. With an interdisciplinary team, physicist Dr Ioanna Mantouvalou reports on this study in the Nature Journal Heritage Science.